176 related articles for article (PubMed ID: 35389141)
1. Macroscopic extranodal extension is an independent predictor of lung metastasis in papillary thyroid cancer.
Hei H; Gong W; Zheng C; Zhou B; Qin J
Endocrine; 2022 Jun; 77(1):73-79. PubMed ID: 35389141
[TBL] [Abstract][Full Text] [Related]
2. Extranodal extension is an independent predictor of extensive nodal metastasis in T1 papillary thyroid cancer.
Hei H; Li Y; Luo Z; Chai X; Zhang H; Zheng C; Zhou B; Gong W; Qin J
Langenbecks Arch Surg; 2022 Jun; 407(4):1647-1652. PubMed ID: 35146548
[TBL] [Abstract][Full Text] [Related]
3. Male patients with papillary thyroid cancer have a higher risk of extranodal extension.
Hei H; Zhou B; Gong W; Zheng C; Qin J
Int J Clin Oncol; 2022 Apr; 27(4):648-654. PubMed ID: 35000041
[TBL] [Abstract][Full Text] [Related]
4. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.
Roh JL; Park JW; Jeong J; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2017 Sep; 116(4):450-458. PubMed ID: 28608492
[TBL] [Abstract][Full Text] [Related]
5. The Prevalence of Extranodal Extension in Papillary Thyroid Cancer Based on the Size of the Metastatic Node: Adverse Histologic Features Are Not Limited to Larger Lymph Nodes.
Rowe ME; Ozbek U; Machado RA; Yue LE; Hernandez-Prera JC; Valentino A; Qazi M; Brandwein-Weber M; Liu X; Wenig BM; Urken ML
Endocr Pathol; 2018 Mar; 29(1):80-85. PubMed ID: 29396810
[TBL] [Abstract][Full Text] [Related]
6. Extent of Extrathyroidal Extension as a Significant Predictor of Nodal Metastasis and Extranodal Extension in Patients with Papillary Thyroid Carcinoma.
Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2017 Feb; 24(2):460-468. PubMed ID: 27654105
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
8. Extranodal Extension Is an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score Matching Analysis.
Zhou TH; Lin B; Wu F; Lu KN; Mao LL; Zhao LQ; Jiang KC; Zhang Y; Zheng WJ; Luo DC
Front Endocrinol (Lausanne); 2021; 12():759049. PubMed ID: 34803921
[TBL] [Abstract][Full Text] [Related]
9. Size distribution of metastatic lymph nodes with extranodal extension in patients with papillary thyroid cancer: a pilot study.
Alpert EH; Wenig BM; Dewey EH; Su HK; Dos Reis L; Urken ML
Thyroid; 2015 Feb; 25(2):238-41. PubMed ID: 25422987
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment and prognosis values of extranodal extension to recurrent laryngeal nerve in papillary thyroid carcinoma.
Abuduwaili M; Aili A; Xia B; Chen Z; Wu Z; Xing Z; Fei Y; Su A
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2341-2349. PubMed ID: 36528844
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up.
Ito Y; Kudo T; Kobayashi K; Miya A; Ichihara K; Miyauchi A
World J Surg; 2012 Jun; 36(6):1274-8. PubMed ID: 22270990
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics of papillary thyroid cancer located in the isthmus with Delphian lymph node metastasis.
Zhao J; Zhang Y; Zheng X
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):635-638. PubMed ID: 35210104
[TBL] [Abstract][Full Text] [Related]
13. Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.
Machens A; Dralle H
Eur J Surg Oncol; 2015 Jun; 41(6):766-72. PubMed ID: 25468749
[TBL] [Abstract][Full Text] [Related]
14. Association of Ultrasound Characteristics With Extranodal Extension in Metastatic Papillary Thyroid Carcinoma.
Qualliotine JR; Coquia SF; Hamper UM; Fakhry C
JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):263-9. PubMed ID: 26846933
[TBL] [Abstract][Full Text] [Related]
15. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.
Lango M; Flieder D; Arrangoiz R; Veloski C; Yu JQ; Li T; Burtness B; Mehra R; Galloway T; Ridge JA
Thyroid; 2013 Sep; 23(9):1099-105. PubMed ID: 23421588
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of extranodal extension in papillary thyroid carcinomas: A propensity score matching analysis and proposal for incorporation into current tumor, lymph node, metastasis staging.
Genpeng L; Pan Z; Tao W; Rixiang G; Jingqiang Z; Zhihui L; Jianyong L
Surgery; 2022 Feb; 171(2):368-376. PubMed ID: 34482990
[TBL] [Abstract][Full Text] [Related]
17. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
18. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
19. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer.
Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z
Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841
[TBL] [Abstract][Full Text] [Related]
20. Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma.
Zhan L; Feng HF; Yu XZ; Li LR; Song JL; Tu Y; Yuan JP; Chen C; Sun SR
BMC Surg; 2022 Jun; 22(1):235. PubMed ID: 35725426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
